Page last updated: 2024-10-21

5-methoxytryptamine and Chronic Disease

5-methoxytryptamine has been researched along with Chronic Disease in 2 studies

5-Methoxytryptamine: Serotonin derivative proposed as potentiator for hypnotics and sedatives.
5-methoxytryptamine : A member of the class of tryptamines that is the methyl ether derivative of serotonin.

Chronic Disease: Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bravo, G1
Ibarra, A1
Guizar-SahagĂșn, G1
Rojas, G1
Hong, E1
Huszka, L1
Zabek, DH1
Doust, JW1

Other Studies

2 other studies available for 5-methoxytryptamine and Chronic Disease

ArticleYear
Indorenate improves motor function in rats with chronic spinal cord injury.
    Basic & clinical pharmacology & toxicology, 2007, Volume: 100, Issue:1

    Topics: 5-Methoxytryptamine; Animals; Chronic Disease; Contusions; Disease Models, Animal; Exploratory Behav

2007
Urinary excretion of n,n-dimethylated tryptamines in chronic schizophrenia. A review of the present status of the hypothesis.
    Canadian Psychiatric Association journal, 1976, Volume: 21, Issue:8

    Topics: 5-Methoxytryptamine; Adult; Bufotenin; Chronic Disease; Epinephrine; Female; Humans; Hydroxyindoleac

1976